| Title |
Cost-Effectiveness Thresholds: the Past, the Present and the Future
|
|---|---|
| Published in |
PharmacoEconomics, February 2018
|
| DOI | 10.1007/s40273-017-0606-1 |
| Pubmed ID | |
| Authors |
Praveen Thokala, Jessica Ochalek, Ashley A. Leech, Thaison Tong |
| Abstract |
Cost-effectiveness (CE) thresholds are being discussed more frequently and there have been many new developments in this area; however, there is a lack of understanding about what thresholds mean and their implications. This paper provides an overview of the CE threshold literature. First, the meaning of a CE threshold and the key assumptions involved (perfect divisibility, marginal increments in budget, etc.) are highlighted using a hypothetical example, and the use of historic/heuristic estimates of the threshold is noted along with their limitations. Recent endeavours to estimate the empirical value of the thresholds, both from the supply side and the demand side, are then presented. The impact on CE thresholds of future directions for the field, such as thresholds across sectors and the incorporation of multiple criteria beyond quality-adjusted life-years as a measure of 'value', are highlighted. Finally, a number of common issues and misconceptions associated with CE thresholds are addressed. |
X Demographics
The data shown below were collected from the profiles of 64 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 21 | 33% |
| United States | 11 | 17% |
| Australia | 5 | 8% |
| Saudi Arabia | 3 | 5% |
| Greece | 2 | 3% |
| Chile | 2 | 3% |
| Spain | 1 | 2% |
| Ireland | 1 | 2% |
| Belgium | 1 | 2% |
| Other | 7 | 11% |
| Unknown | 10 | 16% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 38 | 59% |
| Scientists | 18 | 28% |
| Practitioners (doctors, other healthcare professionals) | 6 | 9% |
| Science communicators (journalists, bloggers, editors) | 2 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 155 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 155 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 23 | 15% |
| Student > Master | 22 | 14% |
| Student > Ph. D. Student | 17 | 11% |
| Other | 12 | 8% |
| Student > Bachelor | 7 | 5% |
| Other | 23 | 15% |
| Unknown | 51 | 33% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 24 | 15% |
| Economics, Econometrics and Finance | 20 | 13% |
| Pharmacology, Toxicology and Pharmaceutical Science | 8 | 5% |
| Social Sciences | 6 | 4% |
| Business, Management and Accounting | 5 | 3% |
| Other | 27 | 17% |
| Unknown | 65 | 42% |
Attention Score in Context
This research output has an Altmetric Attention Score of 51. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 June 2023.
All research outputs
#797,043
of 24,938,276 outputs
Outputs from PharmacoEconomics
#19
of 1,978 outputs
Outputs of similar age
#19,553
of 453,696 outputs
Outputs of similar age from PharmacoEconomics
#1
of 37 outputs
Altmetric has tracked 24,938,276 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,978 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.5. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 453,696 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 37 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.